U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403630) titled 'INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)' on Feb. 04.
Brief Summary: This pre-clinical, experimental study will involve primary samples from patients diagnosed with haematological or solid neoplasms defined as high-risk.
It will be prospective, based on consecutive enrolment of eligible patients at each participating institution.
Study Start Date: May 31, 2023
Study Type: INTERVENTIONAL
Condition:
Acute Leukemia
Multiple Myeloma
Chronic Myeloproliferative Neoplasm
Squamous Cell Carcinoma
Pleural Mesothelioma
Pancrea...